Advances in neuroimaging: Impact on psychiatric practice

Psychiatric Times

Volumn 25, Issue 11, 2008, Pages 18-24

  Eldaief, Mark ^b   Dougherty, Darin ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55849110776     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Dougherty DD, Rauch SL. Brain imaging in psychiatry. In: Dougherty DD, Rauch SL, eds. Essentials of Neuroimaging for Clinical Practice. Arlington, Va: American Psychiatric Publishing; 2004:1-10.
2. Renshaw PF, Rauch SL. Neuroimaging in clinical psychiatry. In: Nicholi AM Jr, ed. The Harvard Guide to Psychiatry. 3rd ed. Cambridge, Mass: Belknap Press; 1999:84-97.
3. Erhart SM, Young AS, Marder SR, Mintz J. Clinical utility of magnetic resonance imaging radiographs for suspected organic syndromes in adult psychiatry. J Clin Psychiatry. 2005;66:968-973.
4. Mueller C, Rufer M, Moergeli H, Bridler R. Brain imaging in psychiatry - a study of 435 psychiatric inpatients at a university clinic. Acta Psychiatr Scand. 2006;114:91-100.
5. Jack CR, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000;55:484-489.
6. Mungas D, Reed BR, Jagust WJ, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology. 2002;59:867-873.
7. Callicott JH. Schizophrenia. In: D'Esposito M, ed. Functional MRI: Applications in Clinical Neurology and Psychiatry. United Kingdom: Informa Healthcare Publishing; 2006:181-195.
8. Wright IC, Rabe-Hesketh S, Mellers J, et al. Meta-analyses of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16-25.
9. Renshaw PF, Wicklund S. In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol Psychiatry. 1988;23:465-475.
10. David AS, Woodruff PW, Howard R, et al. Auditory hallucinations inhibit exogenous activation of auditory association cortex. Neuroreport. 1996;7:932-936.
11. Catani M. Diffusion tensor magnetic resonance imaging tractography in cognitive disorders. Curr Opin Neurol. 2006;19:599-606.
12. Gazzaley A, Small S. Alzheimer's disease. In: D'Esposito M, ed. Functional MRI: Applications in Clinical Neurology and Psychiatry. United Kingdom: Informa Healthcare Publishing; 2006:25-34.
13. Persson J, Lind J, Larsson A, et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology. 2006;66:1029-1033.
14. Deckersbach T, Dougherty DD, Rauch SL. Functional imaging of mood and anxiety disorders. J Neuroimaging. 2006;16:1-10.
15. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675-682.
16. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997;9:471-481.
17. Deckersbach T, Dougherty DD, Rauch SL. Mood and anxiety disorders. In: D'Esposito M, ed. Functional MRI: Applications in Clinical Neurology and Psychiatry. United Kingdom: Informa Healthcare Publishing; 2006:115-135.
18. Abercrombie HC, Schaefer SM, Larson CL, et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport. 1998;9:3301-3307.
19. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999;91:127-139.
20. Rubin E, Sackeim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorder: IV. Comparison of mania and depression. Psychiatry Res. 1995;61:1-10.
21. Blumberg HP, Stern E, Martinez D, et al. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry. 2000;48:1045-1052.
22. Strakowski SM, Delbello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005;10:105-116.
23. Malhi GS, Valenzuela M, Wen W, Sachdev P. Magnetic resonance spectroscopy and its applications in psychiatry. Aust N Z J Psychiatry. 2002;36:31-43.
24. Silverstone PH, McGrath BM, Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord. 2005;7:1-10.
25. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:595-606.
26. Rauch SL, Whalen PJ, Dougherty DD, et al. Neurobiological models of obsessive compulsive disorders. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Practical Management. Boston: Mosby; 1998:222-253.
27. Rauch SL, van der Kolk BA, Fisler RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry. 1996;53:380-387.
28. Callicott JH, Bertolino A, Mattay VS, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000;10:1078-1092.
29. Riehemann S, Volz HP, Stutzer P, et al. Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test-an fMRI study. Eur Arch Psychiatry Clin Neurosci. 2001;251:66-71.
30. Jansma JM, Ramsey NF, Slagter HA, et al. Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci. 2001;13:730-743.
31. Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry. 2006;59:929-939.
32. Van de Ven VG, Formisano E, Röder CH, et al. The spatiotemporal pattern of auditory cortical responses during verbal hallucinations. Neuroimage. 2005;27:644-655.
33. Dierks T, Linden DE, Jandl M, et al. Activation of Heschl's gyrus during auditory hallucinations. Neuron. 1999;22:615-621.
34. Frankle WG, Lamelle M. Neuroreceptor imaging in psychiatric disorders. Ann Nucl Med. 2002;16:437-446.
35. Abi-Dargham A, Laruelle M. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur Psychiatry. 2005;20:15-27.
36. Abou-Saleh MT. Neuroimaging in psychiatry: an update. J Psychosom Res. 2006;61:289-293.
37. Kubicki M, McCarley R, Westin CF, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41:15-30.
38. Kanaan RA, Kim JS, Kaufmann WE, et al. Diffusion tensor imaging in schizophrenia. Biol Psychiatry. 2005;58:921-929.
39. Callicott JH, Egan MF, Mattay VS, et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia [published correction appears in Am J Psychiatry. 2004;161:1145]. Am J Psychiatry. 2003;160:709-719.
40. Erhart SM, Young AS, Marder SR, Mintz J. Clinical utility of magnetic resonance imaging radiographs for suspected organic syndromes in adult psychiatry. J Clin Psychiatry. 2005;66:968-973.
41. Mueller C, Rufer M, Moergeli H, Bridler R. Brain imaging in psychiatry - a study of 435 psychiatric inpatients at a university clinic. Acta Psychiatr Scand. 2006;114:91-100.